Who Paid My Doc
P2b SLE
Research payments
$1,221,519
Through program year 2024, $1,221,519 in research payments was reported against P2b SLE, across 133 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $115,461 | 11 |
| 2023 | Research | $527,046 | 44 |
| 2022 | Research | $579,012 | 78 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kishorkumar Desai Hopkinsville, KY Named on 4 payments
- Michael Burnette Valrico, FL Named on 3 payments
- Alireza Nami Charlotte, NC Named on 3 payments
- Srijana Pandit Rochester Hills, MI Named on 3 payments
- Kamran Chaudhary Schaumburg, IL Named on 3 payments
- Cynthia Aranow Manhasset, NY Named on 3 payments
- Cristina Arriens Oklahoma City, OK Named on 3 payments
- Dhiman Basu Colleyville, TX Named on 3 payments
- Enrique Mendez Lake Charles, LA Named on 3 payments
- Noa Shwartz Bronx, NY Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.